Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
69
SDMHF Quote, Financials, Valuation and Earnings
Last price:
$247.90
Seasonality move
:
2.68%
Day range:
$247.90 - $247.90
52-week range:
$170.00 - $251.50
Dividend yield:
0.3%
P/E ratio:
82.76x
P/S ratio:
7.41x
P/B ratio:
5.08x
Volume:
--
Avg. volume:
1.5K
1-year change:
27.13%
Market cap:
$24.1B
Revenue:
$3B
EPS (TTM):
$3.00
Earnings Data
Next earnings date for SDMHF
Feb 16
2026
Most recent earnings per share
$0.77
Beat by $0.77
(Oct 16/2025)
Consensus Estimate
--
(Oct 16/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SDMHF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/16/2025 | Q3 | -- | $824.6M | $0.77 | -- | -- |
| 07/22/2025 | Q2 | -- | $845.1M | $0.80 | -- | -- |
| 04/16/2025 | Q1 | -- | $783.7M | $0.93 | -- | -- |
| 12/31/2024 | Q4 | -- | $801.4M | $0.50 | -- | -- |
| 10/17/2024 | Q3 | -- | $720M | $0.29 | -- | -- |
| 07/18/2024 | Q2 | -- | $760.6M | $0.54 | -- | -- |
| 03/31/2024 | Q1 | -- | $724.4M | $0.63 | -- | -- |
| 12/31/2023 | Q4 | -- | $761.2M | $0.37 | -- | -- |
| 10/19/2023 | Q3 | -- | -- | $0.30 | -- | -- |
| 07/21/2023 | Q2 | -- | -- | $1.57 | -- | -- |
| 04/20/2023 | Q1 | -- | -- | $1.30 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | $2.12 | -- | -- |
| 10/19/2022 | Q3 | -- | -- | $2.24 | -- | -- |
| 07/21/2022 | Q2 | -- | -- | $2.48 | -- | -- |
| 04/21/2022 | Q1 | -- | -- | $3.29 | -- | -- |
| 02/24/2022 | Q4 | -- | -- | -$0.10 | -- | -- |
| 10/20/2021 | Q3 | -- | -- | $1.89 | -- | -- |
| 07/21/2021 | Q2 | -- | -- | $1.88 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $1.49 | -- | -- |
| 02/15/2021 | Q4 | -- | -- | $1.51 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $1.29 | -- | -- |
| 07/21/2020 | Q2 | -- | -- | $0.80 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.89 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.65 | -- | -- |
Sartorius Stedim Biotech SA Earnings Questions
-
How Much did Sartorius Stedim Biotech SA Generate in Revenue Last Quarter?
Sartorius Stedim Biotech SA reported $824.6M worth of top line sales in its most recent quarter.
-
Did Sartorius Stedim Biotech SA Beat Earnings Last Quarter?
Sartorius Stedim Biotech SA announced earnings per share of $0.77 which represents a beat of analyst forecast a -- per share.
-
Is Sartorius Stedim Biotech SA Profitable?
Sartorius Stedim Biotech SA reported $382.6M that represents $3.93 per share over the last quarter.
-
What is the Analyst Consensus for Sartorius Stedim Biotech SA EPS Next Year?
Sartorius Stedim Biotech SA's earnings are forecast to grow from $1.96 per share to -- per share next year representing an increase of --.
-
When is Sartorius Stedim Biotech SA's Earnings Date?
Sartorius Stedim Biotech SA's next earnings date is February 16, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
